Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.
López-Torrecilla J, Boladeras A, Cabeza MA, Zapatero A, Jove J, Esteban LM, Henriquez I, Casaña M, González-San Segundo C, Gómez-Caamaño A, Mengual JL, Hervás A, Muñoz JL, Sanz G. López-Torrecilla J, et al. Among authors: hervas a. Strahlenther Onkol. 2015 Oct;191(10):792-800. doi: 10.1007/s00066-015-0866-7. Epub 2015 Jul 9. Strahlenther Onkol. 2015. PMID: 26156249
Treatment of localised prostate cancer with radiation therapy: evidence versus opinion.
Guedea F, Ramos A, Herruzo I, Sánchez Calzado JA, Contreras J, Romero J, Craven-Bartle J, Willisch P; SEOR (Spanish Society of Radiation Oncology); López Torrecilla JL, Maldonado X, Sancho G, Zapatero A; UROONCOR (Prostate Group of SEOR); Ferrer M, Pardo Y, Fernández P, Mariño A, Hervás A, Macís V, Boladeras A, Ferrer F; Multicentric Spanish Group of Clinically Localized Prostate Cancer; Davis BJ. Guedea F, et al. Among authors: hervas a. Clin Transl Oncol. 2010 May;12(5):315-7. doi: 10.1007/s12094-010-0511-y. Clin Transl Oncol. 2010. PMID: 20466614 No abstract available.
Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.
López Torrecilla J, Zapatero A, Herruzo I, Calvo FA, Cabeza MA, Palacios A, Guerrero A, Hervás A, Lara P, Ludeña Martínez B, Del Cerro Peñalver E, Nagore G, Sancho G, Mengual JL, Mira M, Mairiño A, Samper P, Pérez S, Castillo I, Martínez Cedrés JC, Ferrer E, Rodriguez S, Maldonado X, Gómez Caamaño A, Ferrer C; Grupo de Investigación GICOR-URONCOR-SEOR. López Torrecilla J, et al. Among authors: hervas a. Clin Transl Oncol. 2014 May;16(5):447-54. doi: 10.1007/s12094-013-1121-2. Epub 2013 Oct 25. Clin Transl Oncol. 2014. PMID: 24682792
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: hervas a. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Rep Pract Oncol Radiother. 2015. PMID: 26109913 Free PMC article. Review.
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort.
Gomez-Iturriaga A, Cabeza Á, Pastor J, Jove J, Casaña M, Caamaño AG, Mengual J, Henríquez I, Muñoz J, Hervás A, Segundo CG. Gomez-Iturriaga A, et al. Among authors: hervas a. Clin Transl Oncol. 2016 Oct;18(10):1026-33. doi: 10.1007/s12094-016-1481-5. Epub 2016 Jan 19. Clin Transl Oncol. 2016. PMID: 26781470
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: hervas a. Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):90-2. doi: 10.1016/j.rpor.2015.06.006. Epub 2015 Jul 20. Rep Pract Oncol Radiother. 2016. PMID: 26900365 Free PMC article.
Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study.
Casas F, Henríquez I, Bejar A, Maldonado X, Alvarez A, González-Sansegundo C, Boladeras A, Ferrer F, Hervás A, Herruzo I, Caro M, Rodriguez I, Ferrer C. Casas F, et al. Among authors: hervas a. Clin Transl Oncol. 2017 Mar;19(3):373-378. doi: 10.1007/s12094-016-1538-5. Epub 2016 Oct 21. Clin Transl Oncol. 2017. PMID: 27770397 Clinical Trial.
185 results